| dc.contributor.author | Chua, Su Jen | |
| dc.contributor.author | Mol, Ben W. | |
| dc.contributor.author | Longobardi, Salvatore | |
| dc.contributor.author | Orvieto, Raoul | |
| dc.contributor.author | Venetis, Christos A. | |
| dc.contributor.author | Lispi, Monica | |
| dc.contributor.author | Storr, Ashleigh | |
| dc.contributor.author | D’Hooghe, Thomas | |
| dc.date.accessioned | 2021-05-10T14:53:01Z | |
| dc.date.available | 2021-05-10T14:53:01Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Chua , S J , Mol , B W , Longobardi , S , Orvieto , R , Venetis , C A , Lispi , M , Storr , A & D’Hooghe , T 2021 , ' Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment : a systematic review and meta-analysis ' , Reproductive Biology and Endocrinology , vol. 19 , no. 1 , 51 . https://doi.org/10.1186/s12958-021-00727-y | en |
| dc.identifier.issn | 1477-7827 | |
| dc.identifier.other | PURE: 193000447 | |
| dc.identifier.other | PURE UUID: 0b96d84f-d0f5-4f0e-9b51-4050acacc139 | |
| dc.identifier.other | RIS: urn:765EA6FCFD3429F70EFE0D40A95C2EE3 | |
| dc.identifier.other | RIS: Chua2021 | |
| dc.identifier.other | PubMed: 33794909 | |
| dc.identifier.other | PubMedCentral: PMC8017804 | |
| dc.identifier.other | Scopus: 85103806999 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16424 | |
| dc.description | Acknowledgments Authors would like to thank Dr. Rui Wang (Department of Obstetrics and Gynecology, University of Monash) who contributed to the statistical analysis. Medical writing assistance was provided by Evelina Matekonyte, inScience Communications, Springer Healthcare Ltd., London, UK, and funded by Merck KGaA, Darmstadt, Germany. Funding This study was funded by Merck KGaA, Darmstadt, Germany. Merck KGaA (Darmstadt, Germany) designed and approved the study, took part in data collection and data analysis, and contributed to the data interpretation and final draft of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. | en |
| dc.format.extent | 13 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Reproductive Biology and Endocrinology | en |
| dc.rights | © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | en |
| dc.subject | Biosimilar | en |
| dc.subject | Follitropin alfa | en |
| dc.subject | IVF | en |
| dc.subject | Ovarian stimulation | en |
| dc.subject | r-hFSH | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R | en |
| dc.title | Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment : a systematic review and meta-analysis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1186/s12958-021-00727-y | |
